Bristol-Myers Squibb Co. (BMY)

• Annual Data
• Quarterly Data

Bristol-Myers Squibb Co., Common-Size Consolidated Income Statement

	12 months ended	Dec 31, 2017		Dec 31, 2016		Dec 31, 2015		Dec 31, 2014		Dec 31, 2013
	Net product sales
	Alliance and other revenues
	Revenues
	Cost of products sold
	Gross margin
	Marketing, selling and administrative
	Research and development
	Operating income
	Interest expense
	Interest income
	Provision for restructuring
	Litigation and other settlements
	Equity in net income of affiliates
	Divestiture gains
	Royalties and licensing income
	Transition and other service fees
	Other alliance and licensing income
	Pension charges
	Intangible asset impairment
	Equity investment impairment
	Written option adjustment
	Loss on debt redemption
	Other
	Other income (expense), net
	Earnings before income taxes
	Provision for income taxes
	Net earnings
	Noncontrolling interest
	Net earnings attributable to BMS

Based on: 10-K (filing date: 2018-02-13), 10-K (filing date: 2017-02-21), 10-K (filing date: 2016-02-12), 10-K (filing date: 2015-02-13), 10-K (filing date: 2014-02-14).